ferric pyrophosphate has been researched along with Kidney Failure, Chronic in 6 studies
*Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marbury, T; Pratt, RD; van der Horst, E; van Heuveln, F | 1 |
| Fang, Y; Gan, L; Hui, AM; Li, K; Pratt, R; Tan, Y; Wei, G; Xie, P; Yuan, X; Zhang, L; Zheng, Q; Zhou, Y; Zuo, L | 1 |
| Chait, Y; Germain, MJ; Nathanson, BH | 1 |
| Fishbane, S; Shah, HH | 1 |
| Fishbane, S; Hazzan, AD; Shah, HH | 1 |
| Amin, NB; Anandan, JV; Besarab, A; Divine, GW; Gupta, A; Vogel, SE; Yee, J | 1 |
2 review(s) available for ferric pyrophosphate and Kidney Failure, Chronic
| Article | Year |
|---|---|
Ferric pyrophosphate citrate as an iron replacement agent for patients receiving hemodialysis.
Topics: Anemia; Clinical Trials as Topic; Diphosphates; Hematinics; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis | 2017 |
Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis.
Topics: Anemia, Iron-Deficiency; Dialysis Solutions; Diphosphates; Ferric Compounds; Hematinics; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis | 2016 |
2 trial(s) available for ferric pyrophosphate and Kidney Failure, Chronic
| Article | Year |
|---|---|
Pharmacokinetics and Safety of Intravenous Ferric Pyrophosphate Citrate: Equivalence to Administration via Dialysate.
Topics: Administration, Intravenous; Citric Acid; Cross-Over Studies; Dialysis Solutions; Diphosphates; Hematinics; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis | 2022 |
Dialysate iron therapy: infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Dialysis Solutions; Diphosphates; Drug Administration Routes; Erythropoietin; Female; Ferritins; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Solubility; Transferrin | 1999 |
2 other study(ies) available for ferric pyrophosphate and Kidney Failure, Chronic
| Article | Year |
|---|---|
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis.
Topics: Citrates; Dialysis Solutions; Diphosphates; Ethnicity; Hematinics; Humans; Iron; Kidney Failure, Chronic; Reproducibility of Results | 2022 |
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol.
Topics: Anemia; Citrates; Ferritins; Hematinics; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Prospective Studies | 2022 |